User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

9600

Interactions with Platform & by Email *

INTERACTIONS

1344

Unique # Participated *

PARTICIPANTS

288

Responses Validated *

VALIDATIONS

55

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   A Prelude.....II-11$100
   Increased Emphasis on Lab Automation Builds Opportunities.....II-21$100
   Market Outlook.....II-3
Developed Regions: Major Revenue Contributors.....II-3
1$100
   Developing Regions: Hotspots for Future Growth.....II-4
Healthcare Trends Influencing Demand for Healthcare Technologies in Developing
  Nations: A Review.....II-4
Growing Healthcare Awareness.....II-4
1$100
   Increased Access to Healthcare.....II-5
Proliferation of Medical Tourism.....II-5
Economic Upheavals in the Recent Past & Impact on Healthcare & Research Equipment
  Market.....II-5
2$200
   Stable Spending Outlook Offers Opportunities for Market Growth.....II-71$100
   Upward Trajectory in Med Tech Sector Gives Impetus to Market Growth.....II-8
Cell Surface Markers Identification Assumes Critical Importance Amid Growing Prevalence
  of Chronic Diseases.....II-8
1$100
   Cell Surface Markers in Stem Cell Research.....II-91$100
   Select Cell Surface Marker s Used in Stem Cell Identification and
  Characterization.....II-10
1$100
   Increasing Significance in Cancer Research.....II-11
Select Markers for Cancer Stem Cell Identification: A Snapshot.....II-11
1$100
   Table 1: Worldwide Incidence of Cancer (2010, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart).....II-12

Table 2: New Cancer Cases in the World by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart).....II-12
1$350
   Table 3: Global Cancer Incidence by Income Group: 2012 (in Thousands) (includes corresponding Graph/Chart).....II-13
Clinical Management of Autoimmune Diseases.....II-13
1$350
   Flow Cytometry Remains the Gold Standard in HIV Testing and Monitoring.....II-14 1$100
   Table 4: Worldwide HIV Prevalence and New Infection Incidence (2014) in Millions (includes corresponding Graph/Chart).....II-15

Table 5: HIV Testing Service Penetration, by Region (2010-2014): Percentage Share Breakdown of Adult Population who received HIV Testing Services in Various Global Regions (includes corresponding Graph/Chart).....II-15
1$350
   Increasing Investments on Advanced Equipment in Disease Diagnosis Underpin Volume
  Growth.....II-16
High Uptake in Drug Discovery Applications Widens Market Prospects.....II-16
1$100
   Growing Focus on Data Management in Research Programs Extends Opportunities.....II-17
Flow Cytometers: A Standard Research Tool.....II-17
1$100
   Technological Advances Boost Cytometric System Sales.....II-18
Third-party Software – Easing Flow Cytometry Data Analysis and Sharing.....II-18
1$100
   Select Leading Software for Flow Cytometry.....II-191$100
   Hematology Analyzers Gain Traction in Cell Surface Marker Identification.....II-20
Innovations in Hematology Analyzers Segment.....II-20
1$100
   Dry Reagents Find Increased Adoption.....II-211$100
   Flow Cytometers Market Characterized by High Consolidation.....II-22
Table 6: Leading Players in the Global Flow Cytometers Market (2014): Percentage Breakdown of Value Sales for Becton Dickinson and Company (BD)/BD Biosciences, Danaher/ Beckman Coulter and Others (includes corresponding Graph/Chart).....II-22
1$350
   Specialist Players Dominate Hematology Analyzers Market.....II-23
Software and Services: The New Area of Competition in Hematology Analyzers
  Segment.....II-23
1$100
   Introduction.....II-24
Types of Cell Surface Markers.....II-24
Applications of Cell Surface Marker Identification.....II-24
In Assessing Aberrant Cell Populations.....II-24
In Distinguishing Minimal Residual Disease.....II-24
To Quantify Cell Populations.....II-24
1$100
   For Evaluating Cell Proliferation.....II-25
In Identification of Foreign Cell Populations.....II-25
In Ascertaining Haematological Condition.....II-25
Product Segments.....II-25
Flow Cytometers.....II-25
Hematology Analyzers.....II-25
1$100
   Reagents.....II-26
Kits .....II-26
End Users.....II-26
Healthcare Facilities.....II-26
Research Entities.....II-26
1$100
   EIDIA to Introduce HISCL KL-6 Marker Diagnostic Kit.....II-27
Helomics™ to Unveil Precision Cellular Analytical Platform™ (PCAP™).....II-27
Bio-Rad Laboratories Unveils VivaFix™ Cell Viability Assays.....II-27
EMD Millipore Launches Amnis® NF?B Translocation kit.....II-27
Sysmex Unveils XN-L Series Automated Hematology Analyzer.....II-27
Sysmex Launches LC-1000 Exfoliative Cell Analyser.....II-27
1$100
   Sysmex Rolls Out HISCL-800 Immunoassay System.....II-28
HORIBA UK Unveils Pentra XLR Compact 5 Part DIFF Haematology Analyser.....II-28
Roche Introduces AMH Fertility Marker.....II-28
Diatron Group Unveils Abacus 3CT Hematology Analyzer.....II-28
Beckman Coulter Launches UniCel DxH 600.....II-28
Sysmex Develops Reagent for Testing Hepatic Fibrosis.....II-28
1$100
   Beckman Coulter Receives FDA Clearance for AQUIOS CL Flow Cytometer.....II-29
Bio-Rad Laboratories Extends Agreement with Beckman Coulter.....II-29
Sysmex to Expand US Reagent Factory.....II-29
Sysmex to Establish New R&D Lab.....II-29
Siemens Healthcare Joins CANCER-ID Consortium.....II-29
Sysmex Expands Reagent Factory in Germany.....II-29
1$100
   EMD Millipore Collaborates with Sysmex.....II-30
eBioscience Inks Distribution Agreement with Binding Site Group.....II-30
The Carlyle Group Acquires Johnson & Johnson’s Ortho-Clinical Diagnostics
  Business.....II-30
Beckman Coulter Bags FDA Clearance for Power Express Sample Processing System.....II-30
Beckman Coulter Signs New Installation Agreement with PCL Alverno.....II-30
Beckman Coulter Teams Up with hc1.com®.....II-30
1$100
   Sysmex Launches i-Square Instrument Factory.....II-31
Sysmex Renames Partec as Sysmex Partec.....II-31
Beckman Coulter Life Sciences to Acquire Xitogen Technologies.....II-31
Sysmex Establishes Sysmex Australia.....II-31
Beckman Coulter Life Sciences Receives FDA Approval for Navios.....II-31
Thorlabs Snaps Up CompuCyte.....II-31
Beckman Coulter Inks New Tri Source Agreement with Premier.....II-31
1$100
   Beckman Coulter Receives FDA Clearance for its Access AccuTnI+3 Troponin I
  Assay.....II-32
Sysmex Inks Collaboration Agreement with National Cancer Center.....II-32
Sysmex Acquires Partec.....II-32
Beckman Coulter Life Sciences Acquires ReaMetrix India’s Flow Cytometry
  Business.....II-32
Sysmex Takes Over Dong Kang Medipia.....II-32
1$100
   Abbott Laboratories (US).....II-33
BD Biosciences (US).....II-33
Beckman Coulter, Inc. (US).....II-33
1$100
   Bio-Rad Laboratories, Inc. (US).....II-341$100
   CellaVision AB (Sweden).....II-35
Dako Denmark A/S (Denmark).....II-35
eBioscience, Inc. (US).....II-35
EMD Millipore (US).....II-35
1$100
   F. Hoffmann-La Roche Ltd. (Switzerland).....II-361$100
   Grifols, S.A (Spain).....II-37
Horiba Ltd. (Japan).....II-37
Mindray Medical International Limited (China).....II-37
1$100
   Ortho-Clinical Diagnostics, Inc. (US).....II-38
QIAGEN N.V. (The Netherlands).....II-38
1$100
   Siemens Healthcare (Germany).....II-39
Sysmex Corporation (Japan).....II-39
Thermo Fisher Scientific, Inc. (US).....II-39
2$200
   Table 7: World Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-411$350
   Table 8: World Historic Review for Cell Surface Markers Identification Equipment by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-421$350
   Table 9: World 14-Year Perspective for Cell Surface Markers Identification Equipment by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).....II-431$350
   Table 10: World Recent Past, Current and Future Analysis for Flow Cytometers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-441$350
   Table 11: World Historic Review for Flow Cytometers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-451$350
   Table 12: World 14-Year Perspective for Flow Cytometers by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).....II-461$350
   Table 13: World Recent Past, Current and Future Analysis for Others by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-471$350
   Table 14: World Historic Review for Others by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-481$350
   Table 15: World 14-Year Perspective for Others by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).....II-491$350
   Table 16: World Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Application - Research and Diagnosis Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-501$350
   Table 17: World Historic Review for Cell Surface Markers Identification Equipment by Application - Research and Diagnosis Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-511$350
   Table 18: World 14-Year Perspective for Cell Surface Markers Identification Equipment by Application - Percentage Breakdown of Revenues for Research and Diagnosis Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).....II-521$350
   A. Market Analysis.....III-1
Outlook.....III-1
Largest Market for Cell Surface Markers Identification Equipment.....III-1
Increased Focus on Cancer Care to Benefit Market.....III-1
1$75
   Cancer Statistics.....III-2
Table 19: New Cancer Cases in the US by Gender and Affected Site: 2014.....III-2
2$200
   Table 20: Cancer Related Deaths in the US by Gender and Body Site: 2014.....III-41$200
   Recovery in Lab Investments to Support Growth.....III-5
Product Innovations Focus on High Volume Applications.....III-5
1$75
   Competitive Scenario.....III-6
BD Biosciences & Beckman Coulter Dominate Flow Cytometers Market.....III-6
Table 21: Leading Players in the US Flow Cytometry Market (2014): Percentage Breakdown of Value Sales for Becton Dickinson and Company (BD)/BD Biosciences, Danaher/ Beckman Coulter and Others (includes corresponding Graph/Chart).....III-6
1$200
   Product Launches.....III-7
Strategic Corporate Developments.....III-7
2$150
   Select Key Players.....III-95$375
   B. Market Analytics.....III-14
Table 22: US Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-14
1$200
   Table 23: US Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-151$200
   Table 24: US 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).....III-161$200
   A. Market Analysis.....III-17
High Focus on Improving Healthcare Augurs Well for Market Growth.....III-17
1$75
   B. Market Analytics.....III-18
Table 25: Canadian Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-18
1$200
   Table 26: Canadian Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-191$200
   Table 27: Canadian 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).....III-201$200
   A. Market Analysis.....III-21
Outlook.....III-21
Product Launches.....III-21
1$75
   Strategic Corporate Developments.....III-221$75
   Select Key Players.....III-231$75
   B. Market Analytics.....III-24
Table 28: Japanese Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-24
1$200
   Table 29: Japanese Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-251$200
   Table 30: Japanese 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).....III-261$200
   A. Market Analysis.....III-27
Outlook.....III-27
European Debt Crisis Weakens Market Momentum in 2012 & 2013.....III-27
1$75
   B. Market Analytics.....III-28
Table 31: Europe Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-28
1$200
   Table 32: Europe Historic Review for Cell Surface Markers Identification Equipment by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-291$200
   Table 33: Europe 14-Year Perspective for Cell Surface Markers Identification Equipment by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).....III-301$200
   Table 34: Europe Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-311$200
   Table 35: Europe Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-321$200
   Table 36: Europe 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).....III-331$200
   A. Market Analysis.....III-34
Outlook.....III-34
B. Market Analytics.....III-34
Table 37: French Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-34
1$200
   Table 38: French Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-351$200
   A. Market Analysis.....III-36
Outlook.....III-36
Strategic Corporate Developments.....III-36
Siemens Healthcare – A Major German Player.....III-36
1$75
   B. Market Analytics.....III-37
Table 39: German Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-37
1$200
   Table 40: German Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-381$200
   A. Market Analysis.....III-39
Outlook.....III-39
B. Market Analytics.....III-39
Table 41: Italian Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-39
1$200
   Table 42: Italian Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-401$200
   A. Market Analysis.....III-41
Outlook.....III-41
Product Launches.....III-41
1$75
   B. Market Analytics.....III-42
Table 43: UK Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-42
1$200
   Table 44: UK Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-431$200
   A. Market Analysis.....III-44
Outlook.....III-44
Grifols, S.A – A Major Spanish Player.....III-44
1$75
   B. Market Analytics.....III-45
Table 45: Spanish Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-45
1$200
   Table 46: Spanish Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-461$200
   A. Market Analysis.....III-47
Outlook.....III-47
B. Market Analytics.....III-47
Table 47: Russian Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-47
1$200
   Table 48: Russian Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-481$200
   A. Market Analysis.....III-49
Outlook.....III-49
Product Launches.....III-49
Select Key Players.....III-49
2$150
   B. Market Analytics.....III-51
Table 49: Rest of Europe Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-51
1$200
   Table 50: Rest of Europe Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-521$200
   A. Market Analysis.....III-53
Outlook.....III-53
Asia-Pacific: The Fastest Growing Regional Market.....III-53
1$75
   B. Market Analytics.....III-54
Table 51: Asia-Pacific Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-54
1$200
   Table 52: Asia-Pacific Historic Review for Cell Surface Markers Identification Equipment by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-551$200
   Table 53: Asia-Pacific 14-Year Perspective for Cell Surface Markers Identification Equipment by Geographic Region - Percentage Breakdown of Revenues for China, India, and Rest of Asia-Pacific Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).....III-561$200
   Table 54: Asia-Pacific Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-571$200
   Table 55: Asia-Pacific Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-581$200
   Table 56: Asia-Pacific 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).....III-591$200
   A. Market Analysis.....III-60
Outlook.....III-60
Domestic Companies Compete with MNCs.....III-60
Corporate Development.....III-60
Mindray Medical International Limited – A Major Chinese Player.....III-60
1$75
   B. Market Analytics.....III-61
Table 57: Chinese Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-61
1$200
   Table 58: Chinese Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-621$200
   A. Market Analysis.....III-63
Outlook.....III-63
Indian Flow Cytometry Market: An Overview.....III-63
Table 59: Flow Cytometry Market in India (2014): Percentage Breakdown of Sales by End-Use Industry - Life Sciences, Clinical Research and Pharmaceutical (includes corresponding Graph/Chart).....III-63
1$200
   Table 60: Indian Market for Flow Cytometers Reagents (2014): Percentage Share Breakdown of Value Sales by Application (includes corresponding Graph/Chart).....III-64
Automated Hematology Analyzers Gaining Traction.....III-64
Corporate Development.....III-64
1$200
   B. Market Analytics.....III-65
Table 61: Indian Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-65
1$200
   Table 62: Indian Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-661$200
   A. Market Analysis.....III-67
Outlook.....III-67
Strategic Corporate Developments.....III-67
1$75
   B. Market Analytics.....III-68
Table 63: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-68
1$200
   Table 64: Rest of Asia-Pacific Historic Review for Cell Surface Markers Identification Equipment Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-691$200
   A. Market Analysis.....III-70
Outlook.....III-70
B. Market Analytics.....III-70
Table 65: Latin America Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-70
1$200
   Table 66: Latin America Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-711$200
   Table 67: Latin America 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).....III-721$200
   A. Market Analysis.....III-73
Outlook.....III-73
B. Market Analytics.....III-73
Table 68: Rest of World Recent Past, Current and Future Analysis for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-73
1$200
   Table 69: Rest of World Historic Review for Cell Surface Markers Identification Equipment by Segment - Flow Cytometers and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-741$200
   Table 70: Rest of World 14-Year Perspective for Cell Surface Markers Identification Equipment by Segment - Percentage Breakdown of Revenues for Flow Cytometers and Others Markets for Years 2007, 2015, and 2020 (includes corresponding Graph/Chart).....III-751$200
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com